Literature DB >> 18370316

Antibody arrays for determination of relative protein abundances.

Grigoriy S Chaga1.   

Abstract

As a large number of genome-sequencing projects reached completion, the attention of the scientific community is turning toward understanding the structure-functions of gene translation products-the proteins as well as the complete complement of proteins-the proteome. One goal of proteomics is to correlate changes in protein abundance with biological processes and disease states. To help accelerate this avenue of proteomics, a significant effort has been devoted to the development of multiplexed methods for protein analyses. We have developed an Antibody Microarray, a chip-based technology for multiparallel determination of relative abundance of hundreds of proteins. The Antibody Microarray is composed of hundreds of distinct monoclonal antibodies printed at high density on a glass slide. It utilizes a novel experimental setup and data analysis algorithm, which enables scientists to assay hundreds of cytosolic, nuclear, and membrane-bound proteins with a single experiment. Examples of biological samples that are analyzed on the Antibody Microarray include tissue samples, cell cultures, and body fluids.

Mesh:

Substances:

Year:  2008        PMID: 18370316     DOI: 10.1007/978-1-60327-047-2_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Development of novel drug delivery systems using phage display technology for clinical application of protein drugs.

Authors:  Kazuya Nagano; Yasuo Tsutsumi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

Review 2.  Phage Display Technology as a Powerful Platform for Antibody Drug Discovery.

Authors:  Kazuya Nagano; Yasuo Tsutsumi
Journal:  Viruses       Date:  2021-01-25       Impact factor: 5.048

Review 3.  Protein microarrays: high-throughput tools for proteomics.

Authors:  Oda Stoevesandt; Michael J Taussig; Mingyue He
Journal:  Expert Rev Proteomics       Date:  2009-04       Impact factor: 3.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.